# FDA Inspection 1195317 - Fertility Institute of New Orleans APC - December 12, 2022

Source: https://www.keypedia.com/records/fda_inspections/fertility-institute-of-new-orleans-apc/5ea915c2-9ffc-4bf9-aa35-40a10aa9ea1d
Source feed: FDA_Inspections

> FDA Inspection 1195317 for Fertility Institute of New Orleans APC on December 12, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195317
- Company Name: Fertility Institute of New Orleans APC
- Inspection Date: 2022-12-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1195317 - 2022-12-12](https://www.keypedia.com/records/fda_inspections/fertility-institute-of-new-orleans-apc/8386f7c9-bcc8-460c-a650-9d9d7144507f)
- [FDA Inspection 1195317 - 2022-12-12](https://www.keypedia.com/records/fda_inspections/fertility-institute-of-new-orleans-apc/d77643f4-eeff-4344-a833-97453f09b869)
- [FDA Inspection 1086006 - 2019-03-04](https://www.keypedia.com/records/fda_inspections/fertility-institute-of-new-orleans-apc/026b6193-670a-4020-b7b0-a288478c792b)

Company: https://www.keypedia.com/companies/fertility-institute-of-new-orleans-apc/1a5ea2f9-1aeb-42e1-98ec-3a061071f27e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d